Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy TELA Bio (TELA) stock

Learn how to easily invest in TELA Bio stock.

TELA Bio, Inc
NASDAQ: TELA - USD
MEDICAL DEVICES
$15.35
-$0.01 (-0.07%)

TELA Bio, Inc is a medical devices business based in the US. TELA Bio shares (TELA) are listed on the NASDAQ and all prices are listed in US Dollars. TELA Bio employs 108 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in TELA Bio

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TELA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

TELA Bio stock price (NASDAQ: TELA)

Use our graph to track the performance of TELA stocks over time.

TELA Bio shares at a glance

Information last updated 2021-07-23.
Latest market close$13.29
52-week range$11.50 - $18.00
50-day moving average $14.78
200-day moving average $14.48
Wall St. target price$20.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy TELA Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy TELA Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TELA Bio price performance over time

Historical closes compared with the close of $13.29 from 2021-06-08

1 week (2021-07-17) N/A
1 month (2021-06-28) -16.31%
3 months (2021-04-28) -2.99%
6 months (2021-01-24) N/A
1 year (2020-07-24) N/A
2 years (2019-07-24) N/A
3 years (2018-07-24) N/A
5 years (2016-07-24) N/A

TELA Bio financials

Revenue TTM $20.4 million
Gross profit TTM $11.5 million
Return on assets TTM -23.74%
Return on equity TTM -90.14%
Profit margin -145.9%
Book value $2.89
Market capitalisation $220.4 million

TTM: trailing 12 months

Shorting TELA Bio shares

There are currently 89,298 TELA Bio shares held short by investors – that's known as TELA Bio's "short interest". This figure is 64.5% down from 251,390 last month.

There are a few different ways that this level of interest in shorting TELA Bio shares can be evaluated.

TELA Bio's "short interest ratio" (SIR)

TELA Bio's "short interest ratio" (SIR) is the quantity of TELA Bio shares currently shorted divided by the average quantity of TELA Bio shares traded daily (recently around 122326.02739726). TELA Bio's SIR currently stands at 0.73. In other words for every 100,000 TELA Bio shares traded daily on the market, roughly 730 shares are currently held short.

However TELA Bio's short interest can also be evaluated against the total number of TELA Bio shares, or, against the total number of tradable TELA Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TELA Bio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 TELA Bio shares in existence, roughly 10 shares are currently held short) or 0.0186% of the tradable shares (for every 100,000 tradable TELA Bio shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against TELA Bio.

Find out more about how you can short TELA Bio stock.

TELA Bio share dividends

We're not expecting TELA Bio to pay a dividend over the next 12 months.

TELA Bio overview

TELA Bio, Inc. , a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. .

Frequently asked questions

What percentage of TELA Bio is owned by insiders or institutions?
Currently 7.344% of TELA Bio shares are held by insiders and 84.489% by institutions.
How many people work for TELA Bio?
Latest data suggests 108 work at TELA Bio.
When does the fiscal year end for TELA Bio?
TELA Bio's fiscal year ends in December.
Where is TELA Bio based?
TELA Bio's address is: 1 Great Valley Parkway, Malvern, PA, United States, 19355
What is TELA Bio's ISIN number?
TELA Bio's international securities identification number is: US8723811084
What is TELA Bio's CUSIP number?
TELA Bio's Committee on Uniform Securities Identification Procedures number is: 872381108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site